The Beiruter
Obesity treatment
-
Obesity treatment - GLP-1 medications - Medicare coverage - Medicaid coverage - Prescription drug affordabilityAmerica has an Ozempic problem, and it isn’t the drug
Despite strong clinical evidence for GLP-1 medications, gaps in Medicare and Medicaid coverage continue to limit access to obesity treatment in the United States.By Yug Patel
